vs
Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and GERON CORP (GERN). Click either name above to swap in a different company.
CHIMERA INVESTMENT CORP is the larger business by last-quarter revenue ($66.2M vs $47.2M, roughly 1.4× GERON CORP). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs -39.0%, a 81.8% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 0.5%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 0.8%).
Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
CIM vs GERN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.2M | $47.2M |
| Net Profit | $28.3M | $-18.4M |
| Gross Margin | — | — |
| Operating Margin | 42.6% | -29.4% |
| Net Margin | 42.8% | -39.0% |
| Revenue YoY | 0.5% | 67.1% |
| Net Profit YoY | 119.3% | 30.3% |
| EPS (diluted) | $0.05 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.2M | — | ||
| Q3 25 | $65.0M | $47.2M | ||
| Q2 25 | $66.0M | $49.0M | ||
| Q1 25 | $69.2M | $39.6M | ||
| Q4 24 | $65.8M | — | ||
| Q3 24 | $66.5M | $28.3M | ||
| Q2 24 | $67.3M | $882.0K | ||
| Q1 24 | $65.1M | $304.0K |
| Q4 25 | $28.3M | — | ||
| Q3 25 | $-580.0K | $-18.4M | ||
| Q2 25 | $35.5M | $-16.4M | ||
| Q1 25 | $167.3M | $-19.8M | ||
| Q4 24 | $-146.5M | — | ||
| Q3 24 | $136.5M | $-26.4M | ||
| Q2 24 | $56.7M | $-67.4M | ||
| Q1 24 | $129.5M | $-55.4M |
| Q4 25 | 42.6% | — | ||
| Q3 25 | -0.5% | -29.4% | ||
| Q2 25 | 54.3% | -25.4% | ||
| Q1 25 | — | -42.2% | ||
| Q4 24 | -222.6% | — | ||
| Q3 24 | — | -99.8% | ||
| Q2 24 | 84.2% | -7860.9% | ||
| Q1 24 | — | -18465.1% |
| Q4 25 | 42.8% | — | ||
| Q3 25 | -0.9% | -39.0% | ||
| Q2 25 | 53.7% | -33.4% | ||
| Q1 25 | 241.7% | -50.1% | ||
| Q4 24 | -222.6% | — | ||
| Q3 24 | 205.4% | -93.5% | ||
| Q2 24 | 84.2% | -7639.8% | ||
| Q1 24 | 198.8% | -18220.4% |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $-0.27 | $-0.03 | ||
| Q2 25 | $0.17 | $-0.02 | ||
| Q1 25 | $1.77 | $-0.03 | ||
| Q4 24 | $-2.06 | — | ||
| Q3 24 | $1.39 | $-0.04 | ||
| Q2 24 | $0.41 | $-0.10 | ||
| Q1 24 | $1.36 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $278.6M | $78.1M |
| Total DebtLower is stronger | $251.5M | — |
| Stockholders' EquityBook value | $2.6B | $248.7M |
| Total Assets | $15.8B | $567.4M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.6M | — | ||
| Q3 25 | $491.5M | $78.1M | ||
| Q2 25 | $250.2M | $77.7M | ||
| Q1 25 | $253.3M | $83.7M | ||
| Q4 24 | $84.0M | — | ||
| Q3 24 | $97.3M | $60.3M | ||
| Q2 24 | $162.3M | $116.9M | ||
| Q1 24 | $169.0M | $189.8M |
| Q4 25 | $251.5M | — | ||
| Q3 25 | $251.0M | — | ||
| Q2 25 | $135.2M | — | ||
| Q1 25 | $134.9M | — | ||
| Q4 24 | $134.6M | — | ||
| Q3 24 | $134.4M | — | ||
| Q2 24 | $62.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | $248.7M | ||
| Q2 25 | $2.6B | $259.5M | ||
| Q1 25 | $2.6B | $268.2M | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.7B | $292.3M | ||
| Q2 24 | $2.6B | $306.7M | ||
| Q1 24 | $2.6B | $344.9M |
| Q4 25 | $15.8B | — | ||
| Q3 25 | $15.1B | $567.4M | ||
| Q2 25 | $14.9B | $555.2M | ||
| Q1 25 | $13.2B | $562.5M | ||
| Q4 24 | $13.1B | — | ||
| Q3 24 | $13.7B | $444.9M | ||
| Q2 24 | $13.1B | $449.4M | ||
| Q1 24 | $12.5B | $482.1M |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-248.9M | $-13.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -8.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-248.9M | — | ||
| Q3 25 | $-137.5M | $-13.6M | ||
| Q2 25 | $-7.4M | $-27.4M | ||
| Q1 25 | $48.8M | $-48.0M | ||
| Q4 24 | $205.7M | — | ||
| Q3 24 | $41.4M | $-58.9M | ||
| Q2 24 | $69.0M | $-53.5M | ||
| Q1 24 | $57.3M | $-62.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-53.7M | ||
| Q1 24 | — | $-62.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6086.6% | ||
| Q1 24 | — | -20680.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 23.4% | ||
| Q1 24 | — | 202.3% |
| Q4 25 | -8.78× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.21× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
